These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2534476)

  • 1. Thymic extracellular matrix in Down's syndrome.
    Fonseca EC; Lannes-Vieira J; Villa-Verde DM; Savino W
    Braz J Med Biol Res; 1989; 22(8):971-4. PubMed ID: 2534476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic deficiency in Down's syndrome.
    Levin S; Schlesinger M; Handzel Z; Hahn T; Altman Y; Czernobilsky B; Boss J
    Pediatrics; 1979 Jan; 63(1):80-7. PubMed ID: 155804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic extracellular matrix in human malnutrition.
    Lyra JS; Madi K; Maeda CT; Savino W
    J Pathol; 1993 Nov; 171(3):231-6. PubMed ID: 8277371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of anti-keratins and anti-thymostimulin antibodies in normal and in Down's syndrome human thymuses.
    Aita M; Amantea A
    Thymus; 1991 May; 17(3):155-65. PubMed ID: 1712130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21).
    Larocca LM; Piantelli M; Valitutti S; Castellino F; Maggiano N; Musiani P
    Clin Immunol Immunopathol; 1988 Nov; 49(2):175-86. PubMed ID: 2971489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix of the human thymus: immunofluorescence studies on frozen sections and cultured epithelial cells.
    Berrih S; Savino W; Cohen S
    J Histochem Cytochem; 1985 Jul; 33(7):655-64. PubMed ID: 3891843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-100 immunoreactive interdigitating cells in normal and in Down's syndrome human thymuses.
    Aita M; Franzé A; Gabrielli F
    Cell Biol Int Rep; 1991 Aug; 15(8):645-59. PubMed ID: 1835904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic epithelial abnormalities in patients with congenital heart disease and Down's syndrome.
    Dybdahl H; Henriques UV
    APMIS; 1993 Jan; 101(1):73-4. PubMed ID: 8457328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thymus morphology in Down's syndrome].
    Medvedev NIu; Popova ED
    Arkh Patol; 1982; 44(6):27-30. PubMed ID: 6215018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution of very late activation antigens-1/6 and very late activation antigen ligands in the normal thymus and in thymoma.
    Ruco LP; Paradiso P; Pittiglio M; Diodoro MG; Gearing AJ; Mainiero F; Gismondi A; Santoni A; Baroni CD
    Am J Pathol; 1993 Mar; 142(3):765-72. PubMed ID: 8456937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, immunological and histopathological evidence for thymic deficiency in Down's syndrome (mongolism).
    Schlesinger M; Levin S; Handzel Z; Hahn T; Altman Y; Chernobilski B; Bos J
    Adv Exp Med Biol; 1976; 66():665-71. PubMed ID: 131476
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal thymic microenvironment in insulin-like growth factor-II transgenic mice.
    Savino W; Cotta-de-Almeida V; van Buul-Offers SC; Koster JG; Dardenne M
    Neuroimmunomodulation; 2005; 12(2):100-12. PubMed ID: 15785112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and immunohistochemical study of Down syndrome thymus.
    Larocca LM; Lauriola L; Ranelletti FO; Piantelli M; Maggiano N; Ricci R; Capelli A
    Am J Med Genet Suppl; 1990; 7():225-30. PubMed ID: 2149952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the fetal extracellular matrix in the nuchal oedema of Down's syndrome.
    Brand-Saberi B; Flöel H; Christ B; Schulte-Vallentin M; Schindler H
    Ann Anat; 1994 Dec; 176(6):539-47. PubMed ID: 7832286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of thymus-specific proteasome subunit β5t in Down syndrome patients.
    Tomaru U; Tsuji T; Kiuchi S; Ishizu A; Suzuki A; Otsuka N; Ito T; Ikeda H; Fukasawa Y; Kasahara M
    Histopathology; 2015 Aug; 67(2):235-44. PubMed ID: 25556590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms governing thymocyte migration: combined role of chemokines and extracellular matrix.
    Savino W; Mendes-Da-Cruz DA; Smaniotto S; Silva-Monteiro E; Villa-Verde DM
    J Leukoc Biol; 2004 Jun; 75(6):951-61. PubMed ID: 15020651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome.
    Paz-Miguel JE; Flores R; Sánchez-Velasco P; Ocejo-Vinyals G; Escribano de Diego J; López de Rego J; Leyva-Cobián F
    J Immunol; 1999 Nov; 163(10):5399-410. PubMed ID: 10553065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of LFA-1 and ICAM-1 in Down syndrome thymus. Implications for abnormal thymocyte maturation.
    Murphy M; Insoft RM; Pike-Nobile L; Derbin KS; Epstein LB
    J Immunol; 1993 Jun; 150(12):5696-703. PubMed ID: 8099939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Histopathological changes in the thymus in children with Down's syndrome.
    Schlesinger M; Levin S; Czernobilsky B; Boss J
    Isr J Med Sci; 1976 Jan; 12(1):79. PubMed ID: 130362
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21).
    Murphy M; Friend DS; Pike-Nobile L; Epstein LB
    J Immunol; 1992 Oct; 149(7):2506-12. PubMed ID: 1388194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.